Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing
Abstract Identification of regulators of osteoblastogenesis that can be pharmacologically targeted is a major goal in combating osteoporosis, a common disease of the elderly population. Here, unbiased kinome RNAi screening in primary murine osteoblasts identified cyclin-dependent kinase 5 (Cdk5) as...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-04-01
|
Series: | Bone Research |
Online Access: | https://doi.org/10.1038/s41413-022-00195-z |